New Research Links GLP-1 Agonists to NAION A study published in JAMA Ophthalmology on July 3, 2024, found that type 2 diabetes patients prescribed GLP-1 agonists were at an increased risk for developing a rare and debilitating eye condition called NAION
When to Talk to a Dermatologist If you've used Melanotan II or are considering it, or if you've noticed any new or changing spots on your skin, it's worth having a conversation with a board-certified dermatologist
10.2337/db16-1303 164
With patent expiries and rising political pressure on drug pricing, the next two years could reshape who gets to benefit from this new era of metabolic medicine.For now, if you are curious about these drugs, talk to your clinician, check coverage options and weigh both the potential benefits and the long-term cost before deciding
Analytical methods such as the Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM) were employed to assess AE risk
Her work has been featured in publications such as Architectural Digest , Womens Health , InStyle , Cosmopolitan , and many others.
